Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3).

Gonzato O, Reinke D, Wilson R, Kasper B, Ruiz Alvarez MJ

Open source

DOI
10.1016/j.eclinm.2026.104192
Published
2026 Oct
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104192,
  title = {Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3).},
  author = {Gonzato O and Reinke D and Wilson R and Kasper B and Ruiz Alvarez MJ},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104192},
  url = {https://doi.org/10.1016/j.eclinm.2026.104192}
}

RIS

TY  - JOUR
TI  - Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3).
AU  - Gonzato O
AU  - Reinke D
AU  - Wilson R
AU  - Kasper B
AU  - Ruiz Alvarez MJ
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104192
UR  - https://doi.org/10.1016/j.eclinm.2026.104192
ER  - 

APA

O, G., D, R., R, W., B, K., & MJ, R. A. (2026). Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3).. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104192

Source records